Status:
ReviewerMember since: 2015
Organization: Hospital Angeles Metropolitano
Application Area: In Architec CI8200 in serum
"In Mexico, the Randox distribution company doesn’t have a good knowledge of the product and they don’t have good logistic of the product. Despite that, it is very good."
Elevated levels of Lp(a) are considered to be both a causal risk factor and independent genetic marker of atherosclerotic disorders. The major challenge with this test is the size variation of apo(a) within Lp(a).
Dependent upon the size of apo(a) in the assay calibrator, many assays under or overestimate apo(a) size in the patient sample. Many Lp(a) measurement techniques suffer size related bias problems resulting in an over estimation of Lp(a) in samples with large apo(a) molecules and an under estimation in samples with small apo(a) molecules.
The antibody used in the Randox Lp(a) method detects the complete Lp(a) molecule ensuring the most accurate and consistent results are returned.
Lipoprotein (a) - Lp(a) Features: